The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Centre — Val de Loire; Centre — Val de Loire; Eure-et-Loir
Location of affected unit(s)
Chartres
Sector
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.10 - Manufacture of basic pharmaceutical products
150 jobs Number of planned job creations
Announcement Date
6 June 2013
Employment effect (start)
11 June 2013
Foreseen end date
31 December 2013
Description
On 5 June 2013, the pharmaceutical company Novo Nordisk has announced to recruit over 150 employees for its plant in Chartres (Eure-et-Loir). As announced the expansion plans are due to the high demand for increased production of diabetes medication. The Danish group is to recruit operators, technicians, engineers and pharmacists. Founded in 1961, the factory Novo Nordisk Chartres employed 49 employees in 1990. The total employment will be close to 900 by the end of 2014. The group has invested 20 million euro per year for ten years in its factory and has changed its working time organization to meet demand. For previously reported restructuring events referring to the group see Novo Nordisk2009 and Novo Nordisk2003.
Sources
7 June 2013: Les Echos
6 June 2013: L'usine Nouvelle
Citation
Eurofound (2013), Novo Nordisk France, Business expansion in France, factsheet number 75495, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/75495.